North Run Capital’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-90,000
| Closed | -$1.54M | – | 19 |
|
|
2016
Q4 | $1.54M | Sell |
90,000
-77,492
| -46% | -$1.33M | 0.47% | 19 |
|
|
2016
Q3 | $5.04M | Sell |
167,492
-27,190
| -14% | -$818K | 0.79% | 25 |
|
|
2016
Q2 | $5.51M | Hold |
194,682
| – | – | 0.91% | 23 |
|
|
2016
Q1 | $5.22M | Sell |
194,682
-2,137
| -1% | -$57.3K | 0.71% | 24 |
|
|
2015
Q4 | $9.49M | Sell |
196,819
-17,590
| -8% | -$848K | 1.12% | 21 |
|
|
2015
Q3 | $7.83M | Hold |
214,409
| – | – | 0.77% | 26 |
|
|
2015
Q2 | $8.08M | Hold |
214,409
| – | – | 0.79% | 24 |
|
|
2015
Q1 | $8.47M | Hold |
214,409
| – | – | 0.93% | 20 |
|
|
2014
Q4 | $8.81M | Hold |
214,409
| – | – | 0.78% | 23 |
|
|
2014
Q3 | $9.48M | Hold |
214,409
| – | – | 0.86% | 24 |
|
|
2014
Q2 | $9.31M | Hold |
214,409
| – | – | 0.91% | 22 |
|
|
2014
Q1 | $8.79M | Hold |
214,409
| – | – | 0.89% | 26 |
|
|
2013
Q4 | $8.51M | Buy |
214,409
+26,185
| +14% | +$1.04M | 1.08% | 21 |
|
|
2013
Q3 | $7.74M | Buy |
188,224
+28,000
| +17% | +$1.15M | 1.01% | 20 |
|
|
2013
Q2 | $6.2M | Buy |
+160,224
| New | +$6.2M | 0.72% | 26 |
|